Taylor Strategies on Behalf of Ptc Therapeutics
Consulting
Based in DC
AI Overview
With $140K in lobbying spend across 5 quarterly filings, Taylor Strategies on Behalf of Ptc Therapeutics is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2019.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $120K |
| 2019 | $20K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Taylor Strategies on Behalf of Ptc Therapeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations
FDA approval process
Seeking drug approval through the FDA.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.